Abstract:The emergence of multidrug-resistant bacteria has created an urgent need for antibiotics with a novel mechanism of action. The bacterial cell division protein FtsZ is an attractive target for the development of novel antibiotics. The benzo[c]phenanthridinium sanguinarine and the dibenzo[a,g]quinolizin-7-ium berberine are two structurally similar plant alkaloids that alter FtsZ function. The presence of a hydrophobic functionality at either the 1-position of 5-methylbenzo[c]phenanthridinium derivatives or the 2-position of dibenzo[a,g]quinolizin-7-ium derivatives is associated with significantly enhanced antibacterial activity. 3-Phenylisoquinoline represents a subunit within the ring-systems of both of these alkaloids. Several 3-phenylisoquinolines and 3-phenylisoquinolinium derivatives have been synthesized and evaluated for antibacterial activity against Staphylococcus aureus and Enterococcus faecalis, including multidrug-resistant strains of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). A number of derivatives were found to have activity against both MRSA and VRE. The binding of select compounds to S. aureus FtsZ (SaFtsZ) was demonstrated and characterized using fluorescence spectroscopy. In addition, the compounds were shown to act as stabilizers of SaFtsZ polymers and concomitant inhibitors of SaFtsZ GTPase activity. Toxicological assessment of select compounds revealed minimal cross-reaction mammalian β-tubulin as well as little or no human cytotoxicity.

Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.

The Synthesis and Antibacterial Activity of Novel 3-O-arylalkylbenzamide Derivatives As FtsZ Inhibitors

Synthesis and Biological Evaluation of Novel FtsZ‐targeted 3‐arylalkoxy‐2,6‐difluorobenzamides as Potential Antimicrobial Agents

Design, Synthesis and Biological Activity Evaluation of Novel 2,6-Difluorobenzamide Derivatives Through FtsZ Inhibition

Synthesis and antibacterial activity of novel icariin derivatives.

Synthesis and Antibacterial Activity of Novel 4‐bromo‐1h‐indazole Derivatives As FtsZ Inhibitors

Design, Synthesis and Antibacterial Activity of Cinnamaldehyde Derivatives As Inhibitors of the Bacterial Cell Division Protein FtsZ

Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents

Phenylacrylamides As Novel Ftsz-Targeted Potential Antimicrobials

Design, Synthesis of Novel 4,5-Dihydroisoxazole-containing Benzamide Derivatives As Highly Potent FtsZ Inhibitors Capable of Killing a Variety of MDR Staphylococcus Aureus.

Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors.

3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents

Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ.

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

Design, Synthesis and Biological Evaluation of 3-(4-halophenyl)-3-oxopropanal and Their Derivatives As Novel Antibacterial Agents

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Design, synthesis and biological evaluation of amphiphilic benzopyran derivatives as potent antibacterial agents against multidrug-resistant bacteria

Design, Synthesis and Structure-Based Optimization of Novel Isoxazole-Containing Benzamide Derivatives As FtsZ Modulators.

Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents.

Synthesis and Antibacterial Activity of Novel Ethyl 2-Alkoxyimino-2-benzimidazol-2-yl Acetates Bearing a Morpholine Group

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-oxazolidinone Derivatives As Antibacterial Agents.